SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008110
Filing Date
2022-05-10
Accepted
2022-05-10 16:16:31
Documents
14
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20220510x8k.htm   iXBRL 8-K 35439
2 EX-99.1 omer-20220510xex99d1.htm EX-99.1 127575
3 GRAPHIC omer-20220510xex99d1001.jpg GRAPHIC 5215
  Complete submission text file 0001558370-22-008110.txt   302280

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20220510.xsd EX-101.SCH 3271
5 EX-101.LAB omer-20220510_lab.xml EX-101.LAB 15367
6 EX-101.PRE omer-20220510_pre.xml EX-101.PRE 10398
8 EXTRACTED XBRL INSTANCE DOCUMENT omer-20220510x8k_htm.xml XML 4664
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 22909839
SIC: 2834 Pharmaceutical Preparations